prostate cancer treatment

The revised Fourth Edition of this highly acclaimed reference is a practical, state-of-the-art, superbly illustrated guide to the evaluation and clinical correlates of prostate biopsy findings. This edition features expanded coverage of mimickers of prostate cancer, a new chapter on immunohistochemistry and molecular techniques, a major update to the Gleason grading system, new information on histologic changes following radiation therapy, and an expanded section on tumors of specialized prostatic stroma. The book contains nearly 300 full-color illustrations.

A companion online image bank provides over 1,800 full-color images of specimens at various magnifications, plus a question-and-answer review of prostate pathology.

prostate cancer treatment

List Price: $ 163.95

Click the link below to read product reviews and buy on Amazon.com if you like it :-

Biopsy Interpretation of the Prostate (Biopsy Interpretation Series)prostate cancer treatment

prostate cancer treatment

  • ISBN13: 9780738213477
  • Condition: New
  • Notes: BUY WITH CONFIDENCE, Over one million books sold! 98% Positive feedback. Compare our books, prices and service to the competition. 100% Satisfaction Guaranteed

Prostate cancer is one of the most common cancers affecting American men, with over 186,000 new cases diagnosed in the United States annually; 1 in 6 men will be diagnosed with prostate cancer during his lifetime. Renowned prostate cancer specialist Sheldon Marks offers the definitive guide for men concerned about or diagnosed with prostate cancer, and for their families.Since the third edition (2003), there have been significant changes in treatment and resources. Working with Dr. Judd Moul, the Chairman of Urology at Duke and one of the world’s top experts on prostate cancer, Marks provides the most up-to- date information on diagnosis, treatment, and common questions. More Info >>

 

prostate cancer treatment

List Price: $ 17.95

Price: $ 7.55

 

Prostate cancer is the most common cancer diagnosis in American men. It is also the most common cancer found among men over fifty in the United States and continues to grow at a rampant rate. If prostate cancer is detected early, it is very curable with the proper treatment.

There are quite a few treatment options to choose from when selecting the appropriate procedure. One of the best procedure options for you to consider is a radical prostatectomy. A radical prostatectomy is a common treatment method that involves the surgical removal of the prostate gland. The radical prostatectomy procedure is mainly encouraged for young, healthy men under the age of 70. A prostatectomy is not typically performed on men 70 and above because of the serious complications that can occur.

Choosing a Surgeon:

It’s suggested that patients seeking the best treatment outcome seek a qualified urologist with training in prostate cancer prostatectomy. With an experienced surgeon, the radical prostatectomy should take no more than two hours to perform, with no need for blood transfusion. Depending upon the urologist’s skill set in performing the procedure, the patient may wear a catheter for only a few days instead of the maximum three weeks.

Radical Prostatectomy:

A radical prostatectomy is the surgical removal of the prostate gland. It is a major surgical procedure which is performed in a hospital with the patient under general anesthesia. This procedure is considered to offer the second greatest chance for long-term survival (the highest cure rates are found at a radiation therapy practice in Georgia where they use a combined radiation procedure). During a radical prostatectomy, the surgeon removes the entire prostate and then reconnects the urethra and bladder. After surgery is complete, patients usually remain in the hospital from two to four days.

Complications to the Prostatectomy Procedure:

The outcome of the treatment, cure and complication rates vary based on the urologist performing the surgery. However, the most common complications following prostate cancer treatment are urinary incontinence (uncontrolled urine leakage) and erectile dysfunction (ED, the inability to sustain an erection sufficient for sexual intercourse). The majority of men receiving this treatment will suffer from some degree of urinary incontinence and ED immediately following surgery, but should gradually improve over time.

A prostate cancer radical prostatectomy is one potential solution. Let’s look at the issue of prostate cancer from a higher level.

Selecting the Proper Treatment that’s Right for You:

Choosing the most appropriate prostate cancer treatment for an individual depends upon several factors. These include:

- Which treatment option is going to offer the best chance of curing the cancer (and be careful here as there are many definitions of “cure” – but the only one that has been proven reliable is 0.2 ng/ml five years post-treatment).

- Potential side effects associated with the different forms of treatment.

- Examining the rate at which the cancer is growing and how fast it’s spreading to determine the most effective course of treatment

- Patient age, life expectancy and general health, including any other medical conditions

- The experience and training of the treating physician

There is always some form of shock to men when diagnosed with this type of cancer. Men need time to react and not rush into any healthcare decision early. Its recommended men review all prostate cancer treatment options, outcomes and complications, with a physician to select the best treatment that’s right for them. And don’t be afraid to ask your physician tough questions – ask them how long they trained on the procedure they recommend, and what their personal cure rate is.

Where to Get Additional Information:

While your healthcare provider is a good source for prostate cancer information and answering your questions/concerns related to your medical condition, it’s also important that if you are diagnosed with prostate cancer that you take the time to educate yourself on this disease. Prostate cancer is usually slow-growing, so you have time to do the research on the best treatment option for you, so check the web, read articles and books, and try to talk with others who have faced the battle you are now facing yourself and find out what they did.

No two patient’s healthcare conditions are exactly alike and recommendations can vary with physicians. You should conduct your own research to learn and understand prostate cancer and all the available treatment options. With very few exceptions, you only have one chance at being cured; with proper knowledge you’ll be able to make the most efficient and effective decision.

About the Author:John Critz helps inform men about prostate cancer treatment options including prostate cancer radical prostatectomy. His company, RCOG helps educate males about radical prostatectomy among other procedures.

Article Source: ArticlesBase.comUnderstanding Radical Prostatectomy As A Prostate Cancer Treatment Option

Technorati Tag: Prostate Cancer

prostate cancer treatment

In July, 2008, British researchers claimed to have won a major victory for prostate cancer treatment. According to recently release reports, a new drug, abiraterone, may be used to treat as many as 80% of patients suffering from advanced forms of prostate cancer.

Researchers worldwide involved in the treatment of prostate cancer are cautiously optimistic, and welcoming what may arguably be the best news in prostate cancer treatment research in the past 15 years. It is thought that larger clinical studies now need to be conducted to determine important side effects of the new drug’s use, as well as the level of its benefits versus the possible drawbacks of the drug treatment.

Abiraterone is a drug manufactured by Cougar Biotechnology Incorporated, and currently being investigated for use in treatment of prostate cancer. It works to block the production of testosterone, which enhances the growth and development of prostate cancer, by inhibiting an enzyme involved in the formation of testosterone.

In drug trials of abiraterone, it appears that the drug may reduce the levels of prostate specific antigen (PSA), as well as shrink prostate cancer tumors. It is currently being tested on 1,200 men worldwide.

In the trials of the new drug conducted at the Institute of Cancer Research and the Royal Marsden Hospital in Britain, the symptoms of prostate cancer occurring in patients with advanced stages and/or with untreatable forms of the disease have shown significant regression. The news offers hope for thousands of men who contract prostate cancer worldwide each year.

Prostate cancer is usually diagnosed in men in the later life stages. The disease often has few symptoms early on, which is a contributing factor to its reaching advanced stages before being detected.

By the time men reach the ages of 40 (higher risk) or 50, it is recommended that they receive annual prostate checkups. Annual checkups should include both physical exams as well as blood tests, to effectively screen for the disease.

The American Cancer Society estimates 186,320 new cases, and 28,660 deaths will result from prostate cancer in the US in 2008. The Society further states that prostate cancer is the second leading cause of cancer death in men in the nation.

One in six men will get prostate cancer in his lifetime, while one in thirty-five men will die from the disease. Death from prostate cancer is currently on the decline, a fact thought to be due to advances in prostate cancer treatment and early detection.

About the Author:James Culp is a prostate cancer survivor and runs ProstAide.org, a blog that keeps track of all the latest prostate cancer therapy options available.
Article Source: ArticlesBase.comBritain Claiming Major Breakthrough In Prostate Cancer Treatment

Technorati Tag: Prostate Cancer

prostate cancer treatment

A recent study has revealed a racial disparity in prostate cancer treatment of patients in the U.S.

The study, conducted in 2007 and reported in the Journal of Urology earlier this year, was led by Dr. Kathryn E. Richert-Boe, of Kaiser Permanente Northwest in Portland, Oregon. It’s objectives were to determine whether differences existed in prostate cancer treatment received by white and African American men at a health maintenance organization where access to medical care (was) theoretically equal for all members and, if so, to determine the reasons for these differences. The study found that African American patients in the early stages of prostate cancer were less likely than white patients to receive aggressive treatment for their disease.

Researchers conducting the study compared the likelihood of treatment with curative intent (TCI) between the two races, adjusting for age, tumor grade, stage, and the presence of comorbid conditions. What the study revealed was that 82 percent of 158 white prostate cancer patients underwent surgical removal of the prostate gland or radiation therapy for their illness; these are considered more aggressive treatments for the disease. Conversely, only 71 percent of 79 African-American patients received the same type of treatment. Dr. Richert-Boe and the team of researchers investigated whether other factors such as tumor grade, age, overall patient health, and even insurance coverage might explain the difference in treatment; they did not.

Prostate cancer is a leading cancer among men in the United States. In the year 2004, over 189,000 men were diagnosed with the disease. When found early, either through a DRE exam or PSA blood test, treatment is often successful. However, if the cancer goes undetected and reaches advanced stages before it is discovered, effective treatment can be much more difficult.

Prostate cancer in the early stages is often not treated aggressively, because the disease is slow-growing. Many doctors choose to monitor tumor growth and development rather than to prescribe more drastic or aggressive measures early on. The study found that while African American men were just as likely to agree to more aggressive treatments such as surgery or radiation therapy, they were only offered those options in 85 percent of the cases, versus 91 percent for white men.

In the end, the study concluded African American men were less likely to receive TCI than white men. Reasons for the findings in the study are not immediately clear. Additional studies including a larger patient sample is thought to be needed at this point to reveal the true nature of racial disparities in prostate cancer treatment.

About the Author:James Culp is a prostate cancer survivor and runs ProstAide.org, a blog that keeps track of all the latest prostate cancer treatment options available.
Article Source: ArticlesBase.comStudy Reveals Disparity In Prostate Cancer Treatment Based On Race

Technorati Tag: Prostate Cancer

prostate cancer treatment prostate cancer
 Page 1 of 10  1  2  3  4  5 » ...  Last »